Gene · 3437
Papers3,172
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,172
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Seneca Valley virus 2B and 3 C proteins attenuate the cGAS-STING signaling pathway by targeting STING for degradation. | Vet Microbiol | 2026 | 41643365 | PubTator, text mining | PubMed |
| A Comprehensive Analysis of Type I Interferon Risk Gene Signatures in Systemic Lupus Erythematosus. | Exp Dermatol | 2026 | 41635152 | PubTator, text mining | PubMed |
| Single-cell profiling reveals reprogrammed hierarchy and disrupted immune-stromal ecosystem in TP53-mutated AML. | Exp Hematol Oncol | 2026 | 41634865 | PubTator, text mining | PubMed |
| Single cell RNA sequencing analysis and molecular biology experiments identify NAFLD-related fibroblasts and highlights seven hub genes in NAFLD. | PLoS One | 2026 | 41628143 | PubTator, text mining | PubMed |
| Type I Interferon Gene Expression and Its Association With Ocular Involvement in Systemic Lupus Erythematosus. | ACR Open Rheumatol | 2026 | 41614297 | PubTator, text mining | PubMed |
| Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank. | Nat Commun | 2026 | 41593088 | PubTator, text mining | PubMed |
| PP2A dysfunction mediated by PPP2R1A deficiency drives cGAS-STING-dependent hyperinflammation in SLE CD14+ monocytes. | Clin Rheumatol | 2026 | 41582267 | PubTator, text mining | PubMed |
| Rheumatoid arthritis and gout: a rare combination or overlooked coexistence? | Arthritis Res Ther | 2026 | 41582139 | PubTator, text mining | PubMed |
| The radiotherapy induced cyclic GMP-AMP-synthase re-localization and immune signature predicts HNSCC treatment efficacy. | Commun Med (Lond) | 2026 | 41545483 | PubTator, text mining | PubMed |
| Stack: In-Context Learning of Single-Cell Biology. | bioRxiv | 2026 | 41542582 | PubTator, text mining | PubMed |
| Exploration of shared gene signatures and molecular mechanisms between psoriasis and COVID-19: evidence from transcriptome data. | Mamm Genome | 2026 | 41530290 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis reveals IFIT3⁺ macrophage-associated ISG20 as a prognostic biomarker and elucidates underlying tumor-suppressive mechanisms in ovarian cancer. | J Ovarian Res | 2026 | 41514449 | PubTator, text mining | PubMed |
| HERC5, IFI6, IFIT3, and OASL as potential diagnostic biomarkers for systemic lupus erythematosus: an integrated bioinformatics, machine learning and clinical validation. | Clin Rheumatol | 2026 | 41432807 | PubTator, text mining | PubMed |
| VILMIR is a trans-acting long noncoding RNA that enhances the host interferon response in human epithelial cells. | J Virol | 2026 | 41378895 | PubTator, text mining | PubMed |
| Identification of five novel hub genes associated with interstitial lung disease in primary Sjögren's syndrome via transcriptome sequencing. | Clin Rheumatol | 2026 | 41212370 | PubTator, text mining | PubMed |
| Exploring the comorbidity mechanism of rheumatoid arthritis and systemic lupus erythematosus through transcriptomics and conducting experimental validation. | Clin Exp Rheumatol | 2026 | 41196273 | PubTator, text mining | PubMed |
| Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection. | Res Sq | 2026 | 37205380 | PubTator, text mining | PubMed |
| Evaluation of host-immune biomarker signatures as multiplex qPCR diagnostic assays: a pilot study toward meeting WHO target product profiles for TB diagnosis in India. | Front Tuberc | 2025 | 42638755 | PubTator, text mining | PubMed |
| Upregulation of interferon-γ activation in patients with anti-interferon-γ autoantibodies immunodeficiency syndrome: insights from single-cell analysis. | Front Immunol | 2025 | 41710026 | PubTator, text mining | PubMed |
| Clinical characteristics of SARS-CoV-2 infection in patients with chronic hepatitis B during interferon antiviral therapy. | Biosaf Health | 2025 | 41541060 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3437/papers?page=4